← Eichor
Condition: Schizophrenia Spectrum Disorder Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Schizophrenia Spectrum Disorder

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Multimodal Intervention to Support Hospital-to-Community Transition in Bipolar Disorder
NA · 1 location(s) · McMaster University · NCT07213492A Bioequivalence Study of PP3M in Patients With Schizophrenia
NA · 1 location(s) · CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. · NCT07493551SPARK Healthy Sleep
NA · 1 location(s) · Indiana University · NCT07119268An Open-Label Study of ML-007C-MA in Adults With Alzheimer's Disease Psychosis
Phase 2 · 3 location(s) · MapLight Therapeutics · NCT07459660Smoking Cessation With Varenicline in Schizophrenia: Antipsychotic-Induced Neurological Symptoms as Correlates
Phase 4 · 1 location(s) · Corporal Michael J. Crescenz VA Medical Center · NCT03495024Psychiatric Multi-omics and Neuroimaging Project
Phase N/A · 1 location(s) · mingjun Zhong · NCT06580860A Mental Health Services Engagement Program for Racial and Ethnic Minority Young Adults
NA · 1 location(s) · New York University · NCT06508450Efficacy and Safety of tACS vs tDCS in Schizophrenia
NA · 1 location(s) · All India Institute of Medical Sciences, Bhubaneswar · NCT06494124MicroRNAs as Biomarkers in First Episode Schizophrenia
NA · 1 location(s) · Northwell Health · NCT07703670Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia
Phase 3 · 20 location(s) · Neurocrine Biosciences · NCT07227818Randomized Withdrawal Study in Patients With Schizophrenia
Phase 3 · 22 location(s) · Vanda Pharmaceuticals · NCT06961968Brain Circuitry Therapeutics for Schizophrenia
NA · 2 location(s) · Indrit Begue · NCT06341517Transcranial Magnetic Stimulation (TMS) for Negative Symptoms in Schizophrenia Spectrum Disorders
NA · 1 location(s) · The University of Texas Health Science Center, Houston · NCT07290738Biomarkers to Enhance Early Schizophrenia Treatment
Phase 4 · 5 location(s) · Northwell Health · NCT06969755A Study to Evaluate Safety and Efficacy of KarXT + KarX-EC as a Treatment for Psychosis Associated With Alzheimer's Dise
Phase 3 · 22 location(s) · Bristol-Myers Squibb · NCT06947941Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder
Phase 1 · 5 location(s) · BioXcel Therapeutics Inc · NCT05025605Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spect
Phase 3 · 61 location(s) · Intra-Cellular Therapies, Inc. · NCT06229210Examining the Efficacy of a Virtual Reality Cognitive Remediation Program for People Living With Psychosis
NA · 1 location(s) · The Royal Ottawa Mental Health Centre · NCT05973110PS-Trauma - Development of Trauma Treatment for Patients With Co-morbid Psychotic Disorders and Traumas
NA · 1 location(s) · Nikolai Albert · NCT07242586"Extended" (Alternate Day) Antipsychotic Dosing
Phase 4 · 1 location(s) · Centre for Addiction and Mental Health · NCT04478838Efficacy of Maintenance Repetitive Transcranial Magnetic Stimulation (rTMS) in Auditory Verbal Hallucinations
NA · 1 location(s) · University Hospital, Caen · NCT05550155Search for Novel Transcranial Magnetic Stimulation (TMS) Targets for Mental Illness
Phase 2 · 2 location(s) · Brigham and Women's Hospital · NCT06376734Study on the Role and Mechanism of Plasma Exosome microRNAs in Cognitive Impairment in First-episode Schizophrenia
Phase N/A · 1 location(s) · Tianjin Anding Hospital · NCT07139171Tau Biomarkers in Late-onset Psychosis (LOP)
Phase N/A · 1 location(s) · Jeremy Koppel · NCT06336382Single and Multiple Ascending Doses of NTX-253 in Healthy Participants and Participants With Stable Schizophrenia
EARLY_Phase 1 · 1 location(s) · Neurosterix · NCT07344948Effectiveness of Trauma Therapy Using Prolonged Exposure for Patients With PTSD and a Comorbid Psychotic Disorder
NA · 1 location(s) · Medicalschool Hamburg · NCT06048172Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations
NA · 1 location(s) · Massachusetts General Hospital · NCT04296604Pharmacokinetics, Safety, Tolerability and Efficacy of a Subcutaneous Long-Acting Injection of Cariprazine (Cariprazine
Phase 1/Phase 2 · 6 location(s) · Mapi Pharma Ltd. · NCT07185815Effects of Smoking on Network Connectivity in Patients With Schizophrenia Symptoms in Scz Patients
NA · 5 location(s) · The Hong Kong Polytechnic University · NCT07441928A Study of Brenipatide in Adult Participants With Schizophrenia
Phase 2 · 102 location(s) · Eli Lilly and Company · NCT07410507
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.